Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of the European Academy of Dermatology and Venereology : JEADV|September 7, 2020
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacyA S Paller, E C Siegfried, E L Simpson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2021
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal PolypsJoaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Investigative Dermatology|June 29, 2019
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic DermatitisChris Callewaert, Teruaki Nakatsuji, Rob Knight, et al.
American Journal of Clinical Dermatology|June 20, 2020
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisLisa A Beck, Diamant Thaçi, Mette Deleuran, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 19, 2021
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthmaTanya M Laidlaw, Claus Bachert, Nikhil Amin, et al.
Advances in Therapy|May 5, 2018
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe AsthmaWilliam W Busse, Jorge F Maspero, Klaus F Rabe, et al.
Rhinology|November 1, 2019
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNPClaus Bachert, S James Zinreich, Peter W Hellings, et al.
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
Allergy|July 16, 2019
Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposisClaus Bachert, Peter W Hellings, Joaquim Mullol, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 4, 2015
Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III StudyMark C Genovese, Roy Fleischmann, Alan J Kivitz, et al.
Pageof 8